Elevance Health Inc.

NYSE: ANTM · Real-Time Price · USD
482.58
12.71 (2.71%)
At close: Jun 28, 2022, 6:00 AM

Elevance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
149.13B 144.35B 138.64B 133.88B 129.22B 124.63B
Cost of Revenue
n/a n/a n/a n/a n/a n/a
Gross Profit
149.13B 144.35B 138.64B 133.88B 129.22B 124.63B
Operating Income
8.71B 8.9B 8.73B 7.92B 6.3B 7.11B
Interest Income
n/a n/a n/a n/a n/a n/a
Pretax Income
7.87B 8.07B 7.92B 7.14B 5.53B 6.33B
Net Income
6.08B 6.22B 6.09B 5.52B 4.23B 4.71B
Selling & General & Admin
16.78B 16.33B 15.91B 16.01B 17.37B 17.59B
Research & Development
n/a n/a n/a n/a n/a n/a
Other Expenses
-87.5B -151.78B -145.82B -141.97B -140.28B -135.12B
Operating Expenses
-70.72B -135.45B -129.91B -125.96B -122.91B -117.53B
Interest Expense
810M 807M 798M 789M 786M 782M
Selling & Marketing Expenses
2.43B n/a n/a n/a n/a n/a
Cost & Expenses
141.26B 136.27B 130.71B 126.75B 123.69B 118.31B
Income Tax Expense
1.79B 1.85B 1.83B 1.61B 1.29B 1.61B
Shares Outstanding (Basic)
240.7M 241.4M 241.77M 243.4M 244.5M 244.94M
Shares Outstanding (Diluted)
243.4M 244.4M 245.5M 246M 247.4M 248.2M
EPS (Basic)
25.15 25.62 24.98 22.58 17.26 18.95
EPS (Diluted)
24.83 25.30 24.67 22.28 17.02 18.68
EBITDA
10.17B 10.28B 10.03B 9.15B 7.49B 8.27B
EBIT
8.82B 9.5B 9.54B 11.83B 12.88B 15.94B
Depreciation & Amortization
1.46B 1.38B 1.3B 1.23B 1.19B 1.17B